The role of the E2F1 transcription factor in the innate immune response to systemic LPS

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 5, 2012, Pages

  Warg, Laura A ^a   Oakes, Judy L ^a   Burton, Rachel ^a   Neidermyer, Amanda J ^c   Rutledge, Holly R ^b   Groshong, Steve ^a,c   Schwartz, David A ^a   Yang, Ivana V ^a,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Gene expression; Mirna; Mrna

Indexed keywords

FIBRIN DEGRADATION PRODUCT; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; LIPOPOLYSACCHARIDE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICRORNA; MICRORNA 101B; MICRORNA 181B; MICRORNA 455; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; TRANSCRIPTION FACTOR E2F1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; GENE EXPRESSION PROFILING; INNATE IMMUNITY; LIVER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTHROMBIN TIME; REGULATORY MECHANISM; SEPSIS;

ANIMALS; BINDING SITES; BLOOD COAGULATION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; LUNG; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; SPLEEN; THROMBOSIS;

EID: 84865787455     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00369.2011     Document Type: Article

References (28)

1. Aldred AJ, Cha MC, Meckling-Gill KA. Determination of a humane endpoint in the L1210 model of murine leukemia. Contemporary topics in laboratory animal science. JAALAS 41: 24-27, 2002.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
3. Bannerman DD, Goldblum SE. Mechanisms of bacterial lipopolysaccharide- induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 284: L899-L914, 2003.
4. Biswas AK, Johnson DG. Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res 72: 13-17, 2012.
5. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854-865, 2005.
6. Chen M, Capps C, Willerson JT, Zoldhelyi P. E2F-1 regulates nuclear factor-_B activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation 106: 2707-2713, 2002.
7. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 107: 57-64, 2011.
8. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 38: S35-S42, 2010.
9. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3: 352-363, 2008.
10. Lashine YA, Seoudi AM, Salah S, Abdelaziz AI. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin Exp Rheumatol 29: 351-357, 2011.
11. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 38: S26-S34, 2010.
12. Lim CA, Yao F, Wong JJ, George J, Xu H, Chiu KP, Sung WK, Lipovich L, Vega VB, Chen J, Shahab A, Zhao XD, Hibberd M, Wei CL, Lim B, Ng HH, Ruan Y, Chin KC. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation. Mol Cell 27: 622-635, 2007.
13. Monk CE, Hutvagner G, Arthur JS. Regulation of miRNA transcription in macrophages in response to Candida albicans. PloS One 5: e13669, 2011.
14. Morton DB, Griffiths PH. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec 116: 431-436, 1985.
15. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10: 111-122, 2010.
16. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11: 163-175, 2011.
17. Opal SM. Endotoxins and other sepsis triggers. Contrib Nephrol 167: 14-24, 2010.
18. Reimers M, Carey VJ. Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol 411: 119-134, 2006.
19. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003.
20. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Muller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun 380: 437-441, 2009.
21. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 140: 805-820, 2010.
22. Tsitsiou E, Lindsay MA. microRNAs and the immune response. Curr Opin Pharmacol 9: 514-520, 2009.
23. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PloS one 4: e7405, 2009.
24. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, Zhu KM. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 394: 184-188, 2010.
25. Weinstein SL, Finn AJ, Dave SH, Meng F, Lowell CA, Sanghera JS, DeFranco AL. Phosphatidylinositol 3-kinase and mTOR mediate lipopolysaccharide-stimulated nitric oxide production in macrophages via interferon-β. J Leukoc Biol 67: 405-414, 2000.
26. Yang IV, Alper S, Lackford B, Rutledge H, Warg LA, Burch LH, Schwartz DA. Novel regulators of the systemic response to lipopolysaccharide. Am J Respir Cell Mol Biol 45: 393-402, 2011.
27. Zhu QY, Liu Q, Chen JX, Lan K, Ge BX. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages J Immunol 185: 7435-7442, 2010.
28. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, Braude AI. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225-1230, 1982.